BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase and Co. lowered its holdings in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) by 28.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,132,377 shares of the biotechnology company's stock after selling 451,829 shares during the period.